4.6 Review

Extracellular Vesicles in Pulmonary Hypertension: A Dangerous Liaison?

Related references

Note: Only part of the references are listed.
Review Medicine, General & Internal

Right Ventricular Failure

Brian A. Houston et al.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Review Biotechnology & Applied Microbiology

Extracellular vesicles and COPD: foe or friend?

Jiankang Wu et al.

Summary: Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory airway disease characterized by progressive airflow limitation. Extracellular vesicles (EVs) play an important role in the pathogenesis of COPD and can serve as diagnostic markers and a potential therapy for the disease. EVs are released by various cell types and carry bioactive substances that enable communication between cells and affect the physiological and pathological functions of the body.

JOURNAL OF NANOBIOTECHNOLOGY (2023)

Review Pharmacology & Pharmacy

Impact of extracellular vesicles on the pathogenesis, diagnosis, and potential therapy in cardiopulmonary disease

Yixel M. M. Soto-Vazquez et al.

Summary: Cardiopulmonary diseases, including chronic pulmonary disease and cardiovascular disease, are major global causes of morbidity and mortality. Extracellular vesicles play a significant role in the pathogenesis, diagnosis, and potential treatment of these diseases. They are membrane-bound vesicles released by various cell types, containing proteins, proteases, and microRNAs, and are involved in intercellular communication. This review article discusses the role of extracellular vesicles in cardiovascular, pulmonary, and infection-related cardiopulmonary diseases.

FRONTIERS IN PHARMACOLOGY (2023)

Review Oncology

The therapeutic potential of exosomes in lung cancer

Hongyuan Liang et al.

Summary: Lung cancer is a common malignancy with no effective treatment for metastatic advanced cases. Exosomes, nano-extracellular vesicles produced by somatic cells, play a crucial role in the development and maintenance of normal physiological processes. They can transport various substances and signals, and have shown promise in suppressing cancer cell growth and enhancing treatment sensitivity. Their stability, target specificity, biocompatibility, and low immunogenicity make them a potential vehicle for lung cancer therapy.

CELLULAR ONCOLOGY (2023)

Review Cardiac & Cardiovascular Systems

Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Pulmonary Hypertension: A Comprehensive Review of Preclinical Studies

Ji-Hong Xu et al.

Summary: Pulmonary hypertension is a common complication of many diseases and mesenchymal stem cell-derived extracellular vesicles have shown promise in repairing damaged tissues and regulating inflammation, making them a potential treatment for pulmonary hypertension.

JOURNAL OF INTERVENTIONAL CARDIOLOGY (2022)

Article Peripheral Vascular Disease

MiR-1249 on Endothelial Extracellular Vesicles Mediates Cigarette Smoke-Induced Pulmonary Hypertension by Inhibiting HDAC10 (Histone Deacetylase 10)-NFκB (Nuclear Factor κB)-CaSR (Calcium-Sensing Receptor) Cascade

Yuan Su et al.

Summary: This study found that cigarette smoke-enriched microRNA-1249 can promote excessive proliferation and anti-apoptotic status of pulmonary artery smooth muscle cells, leading to the development of pulmonary hypertension. Inhibition of the histone deacetylase 10-NFκB-calcium-sensing receptor cascade can effectively suppress the proliferative capacity and anti-apoptotic ability of pulmonary artery smooth muscle cells, thereby slowing the progression of pulmonary hypertension.

HYPERTENSION (2022)

Article Biochemistry & Molecular Biology

MircoRNA in Extracellular Vesicles from Patients with Pulmonary Arterial Hypertension Alters Endothelial Angiogenic Response

Avinash Khandagale et al.

Summary: In this study, altered miR profiles were found in circulating EVs from PAH patients compared to healthy controls. Inhibition of miR-486-5p or overexpression of miR-26a-5p could attenuate the proangiogenic and proliferative effects of PAH EVs. These effects of miRs were mediated through NF-kappa B activation.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Cardiac & Cardiovascular Systems

Extracellular vesicles derived from endothelial cells in hypoxia contribute to pulmonary artery smooth muscle cell proliferation in-vitro and pulmonary hypertension in mice

Tianji Chen et al.

Summary: The communication between pulmonary vascular endothelial cells and pulmonary artery smooth muscle cells is crucial for maintaining vascular homeostasis. Disruptions in this cell-cell communication are implicated in the pathogenesis of pulmonary vascular remodeling in pulmonary hypertension. This study investigates the role of extracellular vesicles derived from pulmonary vascular endothelial cells, specifically their microRNA cargo, in regulating pulmonary artery smooth muscle cell proliferation and vascular remodeling in pulmonary hypertension. The increase in pro-proliferative miR-210-3p in hypoxia-derived extracellular vesicles contributes to the proliferation of pulmonary artery smooth muscle cells and the development of pulmonary hypertension.

PULMONARY CIRCULATION (2022)

Article Hematology

Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report

Axel Rosell et al.

Summary: The study found that COVID-19 patients have significantly higher levels of circulating EV TF activity compared to healthy controls. This increased activity was associated with disease severity, mortality, and markers like D-dimer, indicating a potential role of EV TF in driving thrombosis in COVID-19 patients.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2021)

Review Medicine, General & Internal

Pulmonary Arterial Hypertension

Paul M. Hassoun

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Pharmacology & Pharmacy

Exosomal miR-211 contributes to pulmonary hypertension via attenuating CaMK1/PPAR-γaxis

Shuhao Zhang et al.

Summary: This study identified that exosomal miR-211 promotes pulmonary hypertension in rats by inhibiting the CaMK1/PPAR-gamma axis and enhancing PASMC proliferation.

VASCULAR PHARMACOLOGY (2021)

Article Medicine, General & Internal

Prostacyclin Analogues Inhibit Platelet Reactivity, Extracellular Vesicle Release and Thrombus Formation in Patients with Pulmonary Arterial Hypertension

Aleksandra Gasecka et al.

Summary: The study showed that PAH patients treated with prostacyclin analogues had impaired platelet reactivity, EV release, and thrombus formation compared to those not receiving prostacyclin analogues.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Critical Care Medicine

Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances

Bradley A. Maron et al.

Summary: The diagnosis and management of pulmonary arterial hypertension have seen advances in early diagnosis, multiple pharmacotherapeutics, and new risk factors becoming focal points. Developmental biology may be useful in predicting incident PAH.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2021)

Article Medicine, General & Internal

Circulating Extracellular Vesicles Are Associated with Disease Severity and Interleukin-6 Levels in COPD: A Pilot Study

Dario Nieri et al.

Summary: The study grouped 35 COPD patients and found an increase in EEV and MEV levels with disease severity, along with a significant correlation with IL-6. This suggests that EV could serve as markers for high-risk extrapulmonary events.

JOURNAL OF CLINICAL MEDICINE (2021)

Article Medicine, Research & Experimental

Plasma exosomal miR-596: a novel biomarker predicts survival in patients with idiopathic pulmonary artery hypertension

Yang Huang et al.

Summary: High levels of plasma exosomal miR-596 were significantly associated with disease severity and poor prognosis of patients with idiopathic pulmonary arterial hypertension (IPAH).

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2021)

Review Biochemistry & Molecular Biology

Critical Review of the Evolution of Extracellular Vesicles' Knowledge: From 1946 to Today

Erica Bazzan et al.

Summary: Extracellular vesicles (EVs) are a family of particles/vesicles found in blood and body fluids, playing important roles in cell communication and regulation of cell processes. Recent years have seen increased interest in the content and function of EVs, but this has also led to confusion in their classification and naming. This review analyzes the evolution of knowledge and definition of EVs over the years.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Cardiac & Cardiovascular Systems

Platelet and Endothelial Activation as Potential Mechanisms Behind the Thrombotic Complications of COVID-19 Patients

Paola Canzano et al.

Summary: The authors suggest that the cytokine storm in COVID-19 patients can lead to sustained cell-based activation of coagulation and altered platelet activity, which can be intervened through prophylactic anticoagulant treatment.

JACC-BASIC TO TRANSLATIONAL SCIENCE (2021)

Review Cardiac & Cardiovascular Systems

Epidemiology of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension: identification of the most accurate estimates from a systematic literature review

Laurence Leber et al.

Summary: This systematic review critically assessed the incidence and prevalence estimates of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension, highlighting a wide range of estimates in European adult populations. The most reliable estimates were obtained from recent national systematic registry data, aiding in resource allocation and detection rate improvements.

PULMONARY CIRCULATION (2021)

Article Biochemistry & Molecular Biology

Mesenchymal Stem Cell Extracellular Vesicles Reverse Sugen/Hypoxia Pulmonary Hypertension in Rats

James R. Klinger et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2020)

Article Hematology

Role of Extracellular Vesicles in Pulmonary Arterial Hypertension Modulation of Pulmonary Endothelial Function and Angiogenesis

Avinash Khandagale et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)

Review Biochemistry & Molecular Biology

Emerging role of extracellular vesicles in the respiratory system

Joshua Holtzman et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2020)

Review Medicine, General & Internal

Pulmonary Hypertension: A Brief Guide for Clinicians

Stacy A. Mandras et al.

MAYO CLINIC PROCEEDINGS (2020)

Article Hematology

Increased levels of platelet-derived microparticles in pulmonary hypertension

Aiko Ogawa et al.

THROMBOSIS RESEARCH (2020)

Article Biochemistry & Molecular Biology

Activated PMN Exosomes: Pathogenic Entities Causing Matrix Destruction and Disease in the Lung

Kristopher R. Genschmer et al.

Article Respiratory System

Pathophysiology of the right ventricle and of the pulmonary circulation in pulmonary hypertension: an update

Anton Vonk Noordegraaf et al.

EUROPEAN RESPIRATORY JOURNAL (2019)

Letter Cardiac & Cardiovascular Systems

Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension

Djuro Kosanovic et al.

PULMONARY CIRCULATION (2019)

Article Biochemistry & Molecular Biology

A Potential Role for Exosomal Translationally Controlled Tumor Protein Export in Vascular Remodeling in Pulmonary Arterial Hypertension

Elisabet Ferrer et al.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2018)

Review Cardiac & Cardiovascular Systems

Epidemiology and treatment of pulmonary arterial hypertension

Edmund M. T. Lau et al.

NATURE REVIEWS CARDIOLOGY (2017)

Review Respiratory System

The pathophysiology of chronic thromboembolic pulmonary hypertension

Gerald Simonneau et al.

EUROPEAN RESPIRATORY REVIEW (2017)

Article Cardiac & Cardiovascular Systems

Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice

Jason M. Aliotta et al.

CARDIOVASCULAR RESEARCH (2016)

Review Critical Care Medicine

A global view of pulmonary hypertension

Marius M. Hoeper et al.

LANCET RESPIRATORY MEDICINE (2016)

Article Critical Care Medicine

Proinflammatory Signature of the Dysfunctional Endothelium in Pulmonary Hypertension Role of the Macrophage Migration Inhibitory Factor/CD74 Complex

Morane Le Hiress et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2015)

Review Biotechnology & Applied Microbiology

Extracellular Membrane Vesicles as Vehicles for Brain Cell-to-Cell Interactions in Physiological as well as Pathological Conditions

Gabriella Schiera et al.

BIOMED RESEARCH INTERNATIONAL (2015)

Review Cardiac & Cardiovascular Systems

Microvesicles as Cell-Cell Messengers in Cardiovascular Diseases

Xavier Loyer et al.

CIRCULATION RESEARCH (2014)

Article Cardiac & Cardiovascular Systems

Induction of pulmonary hypertensive changes by extracellular vesicles from monocrotaline-treated mice

Jason M. Aliotta et al.

CARDIOVASCULAR RESEARCH (2013)

Review Cardiac & Cardiovascular Systems

Pulmonary Arterial Hypertension Epidemiology and Registries

Michael D. McGoon et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)

Article Cardiac & Cardiovascular Systems

A Role for miR-145 in Pulmonary Arterial Hypertension Evidence From Mouse Models and Patient Samples

Paola Caruso et al.

CIRCULATION RESEARCH (2012)

Article Medicine, General & Internal

Prevalence of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension in the United States

Noam Y. Kirson et al.

CURRENT MEDICAL RESEARCH AND OPINION (2011)

Article Cardiac & Cardiovascular Systems

Increased platelet, leukocyte and endothelial microparticles predict enhanced coagulation and vascular inflammation in pulmonary hypertension

Philipp Diehl et al.

JOURNAL OF THROMBOSIS AND THROMBOLYSIS (2011)

Article Critical Care Medicine

Circulating Microparticles from Pulmonary Hypertensive Rats Induce Endothelial Dysfunction

Simon Tual-Chalot et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2010)

Review Physiology

Animal models of pulmonary arterial hypertension: the hope for etiological discovery and pharmacological cure

Kurt R. Stenmark et al.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2009)

Article Cardiac & Cardiovascular Systems

Increased CD62e+ Endothelial Microparticle Levels Predict Poor Outcome in Pulmonary Hypertension Patients

Nicolas Amabile et al.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2009)

Article Hematology

Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism

Francesco Dentali et al.

THROMBOSIS RESEARCH (2009)

Article Critical Care Medicine

Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension

Babe Bakouboula et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Critical Care Medicine

Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension

Nicolas Amabile et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)

Article Urology & Nephrology

Circulating endothelial microparticles are associated with vascular dysfunction in patients with end-stage renal failure

N Amabile et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2005)

Article Biochemistry & Molecular Biology

Endoglin promotes endothelial cell proliferation and TGF-β/ALK1 signal transduction

F Lebrin et al.

EMBO JOURNAL (2004)

Article Medicine, General & Internal

Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism

V Pengo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2004)